中枢神经系统电刺激对急性脑缺血的神经保护作用:临床前研究的荟萃分析
该荟萃分析系统检索Medline,纳入21项研究共28个实验、350只动物,评估中枢神经系统电刺激对急性脑缺血最终梗死体积的影响。结果显示电刺激总体使梗死体积减少37%(95%CI 34%-40%,P<0.001),但不同刺激策略间存在显著异质性(I2=93.1%)。缺血区内刺激中仅阴极半球刺激显著减少梗死体积27%(95%CI 22%-33%,P<0.001),且其偏倚风险最低、转化准备度最高。
要点
- 电刺激总体减少临床前急性脑缺血动物最终梗死体积37%。
- 不同刺激策略疗效异质,仅阴极半球刺激在缺血区内刺激中显著有效。
- 阴极半球刺激偏倚风险最低,最适合推进早期人体临床试验。
核心结论
- 电刺激可减少临床前急性脑缺血的最终梗死体积。
- 阴极半球刺激证据最稳健,可能适合作为神经保护干预推进早期人体临床试验。
研究设计与样本
- 系统检索Medline,纳入对照的临床前急性脑缺血电刺激研究。
- 共21项研究、28个实验、350只动物,按6种刺激策略分类。
- 采用随机效应荟萃分析评估电刺激对最终梗死体积的修改作用。
- 使用正式评定量表评估研究层面偏倚风险和干预层面转化准备度。
主要发现
- 电刺激组动物最终梗死体积较对照组减少37%(95%CI 34%-40%,P<0.001)。
- 刺激策略间疗效存在异质性(I2=93.1%,Pheterogeneity<0.001)。
- 缺血区内刺激策略中,仅阴极半球刺激显著减少梗死体积27%(95%CI 22%-33%,P<0.001)。
- 远隔缺血区刺激策略(顶核刺激、丘脑底血管扩张区刺激、背侧中脑导水管周围灰质刺激)均使梗死体积减少约一半。
- 阴极半球刺激研究偏倚风险最低,且干预层面证据质量最高,支持推进临床测试。
关键数值与推荐
- 电刺激总体减少最终梗死体积37%(95%CI 34%-40%,P<0.001)。
- 阴极半球刺激减少梗死体积27%(95%CI 22%-33%,P<0.001)。
- 远隔缺血区刺激减少梗死体积约一半(原文未报告具体数值)。
- 刺激策略间异质性I2=93.1%,Pheterogeneity<0.001。
临床怎么用
- 阴极半球刺激可作为急性脑缺血神经保护的首选转化候选策略。
- 远隔缺血区刺激策略在临床前也显示显著减少梗死体积,值得进一步评估。
- 临床前证据支持设计早期人体临床试验验证阴极半球刺激的神经保护作用。
局限性
- 仅检索Medline,可能遗漏其他数据库的研究。
- 纳入研究数量有限(21项研究、350只动物),刺激策略间异质性高(I2=93.1%)。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Background and Purpose- Brain electrical stimulation, widely studied to facilitate recovery from stroke, has also been reported to confer direct neuroprotection in preclinical models of acute cerebral ischemia. Systematic review of controlled preclinical acute cerebral ischemia studies would aid in planning for initial human clinical trials. Methods- A systematic Medline search identified controlled, preclinical studies of central nervous system electrical stimulation in acute cerebral ischemia. Studies were categorized among 6 stimulation strategies. Three strategies applied different stimulation types to tissues within the ischemic zone (cathodal hemispheric stimulation [CHS], anodal hemispheric stimulation, and pulsed hemispheric stimulation), and 3 strategies applied deep brain stimulation to different neuronal targets remote from the ischemic zone (fastigial nucleus stimulation, subthalamic vasodilator area stimulation, and dorsal periaqueductal gray stimulation). Random-effects meta-analysis assessed electrical stimulation modification of final infarct volume. Study-level risk of bias and intervention-level readiness-for-translation were assessed using formal rating scales. Results- Systematic search identified 28 experiments in 21 studies, including a total of 350 animals, of electrical stimulation in preclinical acute cerebral ischemia. Overall, in animals undergoing electrical stimulation, final infarct volumes were reduced by 37% (95% CI, 34%-40%; P<0.001), compared with control. There was evidence of heterogeneity of efficacy among stimulation strategies (I2=93.1%, Pheterogeneity<0.001). Among the within-ischemic zone stimulation strategies, only CHS significantly reduced the infarct volume (27 %; 95% CI, 22%-33%; P<0.001); among the remote-from ischemic zone approaches, all (fastigial nucleus stimulation, subthalamic vasodilator area stimulation, and dorsal periaqueductal gray stimulation) reduced infarct volumes by approximately half. On formal rating scales, CHS studies had the lowest risk of bias, and CHS had the highest overall quality of intervention-level evidence supporting readiness to proceed to clinical testing. Conclusions- Electrical stimulation reduces final infarct volume across preclinical studies. CHS shows the most robust evidence and is potentially appropriate for progression to early-stage human clinical trial testing as a promising neuroprotective intervention.
引用
- Bahr Hosseini M, Hou J, Bikson M, et al. Central Nervous System Electrical Stimulation for Neuroprotection in Acute Cerebral Ischemia: Meta-Analysis of Preclinical Studies. Stroke. 2019. PMID: 31480966. doi:10.1161/STROKEAHA.119.025364
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。